Table 2 Comparison of the HSU values of the EQ-5D-3L tool across the demographic and clinical characteristics of Covid-19 patients admitted to a treatment centre in the Arsi Zone, 2020–2021
Variable | Health utility value (EQ-5D-3L) | |||||
|---|---|---|---|---|---|---|
Median | IQR (P25, P75) | Mean | SD | p value | ||
Sex | ||||||
Female | 0.787 | 0.596 | 0.833 | 0.684 | 0.302 | 0.818 |
Male | 0.787 | 0.596 | 0.854 | 0.689 | 0.274 | |
Age | ||||||
0–24 | 0.787 | 0.596 | 1.000 | 0.783 | 0.199 | < 0.001 |
25–34 | 0.787 | 0.596 | 1.000 | 0.778 | 0.213 | |
35–44 | 0.787 | 0.596 | 0.787 | 0.649 | 0.328 | |
45–54 | 0.691 | 0.596 | 0.854 | 0.653 | 0.213 | |
55+ | 0.596 | 0.596 | 0.787 | 0.567 | 0.314 | |
Residence | ||||||
Rural | 0.787 | 0.596 | 0.854 | 0.692 | 0.282 | 0.967 |
Urban | 0.787 | 0.596 | 0.833 | 0.685 | 0.288 | |
Comorbidity | ||||||
No | 0.787 | 0.596 | 1.000 | 0.777 | 0.257 | < 0.001 |
Yes | 0.596 | 0.596 | 0.787 | 0.574 | 0.279 | |
Hypertension | ||||||
No | 0.787 | 0.596 | 0.854 | 0.699 | 0.285 | 0.001 |
Yes | 0.596 | 0.596 | 0.787 | 0.580 | 0.267 | |
Chronic cardiac diseases | ||||||
No | 0.787 | 0.596 | 0.854 | 0.697 | 0.280 | 0.004 |
Yes | 0.596 | 0.596 | 0.787 | 0.518 | 0.320 | |
Chronic pulmonary disease | ||||||
No | 0.787 | 0.596 | 0.854 | 0.703 | 0.277 | < 0.001 |
Yes | 0.596 | 0.596 | 0.596 | 0.499 | 0.311 | |
Asthma | ||||||
No | 0.787 | 0.596 | 0.854 | 0.706 | 0.252 | < 0.001 |
Yes | 0.596 | 0.469 | 0.596 | 0.487 | 0.329 | |
Chronic kidney disease | ||||||
No | 0.787 | 0.596 | 0.854 | 0.690 | 0.286 | 0.029 |
Yes | 0.596 | 0.361 | 0.596 | 0.535 | 0.186 | |
Diabetes mellitus | ||||||
No | 0.787 | 0.596 | 1.000 | 0.711 | 0.281 | < 0.001 |
Yes | 0.596 | 0.596 | 0.787 | 0.575 | 0.280 | |
Malignancy | ||||||
No | 0.787 | 0.596 | 0.854 | 0.687 | 0.288 | 0.859 |
Yes | 0.787 | 0.596 | 0.833 | 0.708 | 0.147 | |
HIV/AIDS | ||||||
No | 0.787 | 0.596 | 0.843 | 0.688 | 0.285 | 0.354 |
Yes | 0.692 | 0.596 | 0.787 | 0.607 | 0.270 | |
Dexamethasone used | ||||||
No | 0.787 | 0.596 | 1.000 | 0.735 | 0.280 | < 0.001 |
Yes | 0.596 | 0.596 | 0.787 | 0.571 | 0.262 | |
Intranasal oxygen used | ||||||
No | 0.787 | 0.787 | 1.000 | 0.816 | 0.180 | < 0.001 |
Yes | 0.596 | 0.596 | 0.596 | 0.500 | 0.305 | |
Length of hospital stay | ||||||
1–7 days | 0.691 | 0.596 | 0.866 | 0.718 | 0.227 | 0.002 |
8–14 days | 0.787 | 0.596 | 1.000 | 0.719 | 0.283 | |
15–21 days | 0.596 | 0.596 | 0.787 | 0.622 | 0.297 | |
22–28 days | 0.596 | 0.596 | 0.787 | 0.715 | 0.197 | |
More than 28 days | 0.596 | 0.469 | 0.787 | 0.604 | 0.241 | |
Overall | 0.787 | 0.596 | 0.833 | 0.688 | 0.285 | |